login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
OYSTER POINT PHARMA INC (OYST) Stock News
USA
- NASDAQ:OYST -
US69242L1061
-
Common Stock
11.17
USD
+0.02 (+0.18%)
Last: 12/30/2022, 8:00:02 PM
11.17
USD
0 (0%)
After Hours:
12/30/2022, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
OYST Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
UNP
KMPR
AAPL
SNAP
...
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
3 years ago - By: InvestorPlace
- Mentions:
DIS
AAPL
DVN
VTRS
...
The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year
3 years ago - By: InvestorPlace
- Mentions:
BIIB
BNTX
PFE
INCY
...
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
3 years ago - By: The Motley Fool
- Mentions:
VTRS
Why Viatris Stock Is Jumping Today
3 years ago - By: Benzinga
- Mentions:
VTRS
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
3 years ago - By: InvestorPlace
- Mentions:
VTRS
Viatris (VTRS) Stock Pops 17% on Acquisition News
3 years ago - By: Kahn Swick & Foti, LLC
OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST
3 years ago - By: Oyster Point Pharma, Inc.
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 years ago - By: The Motley Fool
- Mentions:
ABBV
PFE
ABT
VTRS
Better Dividend Stock: AbbVie or Viatris?
3 years ago - By: Seeking Alpha
Oyster Point Pharma GAAP EPS of -$1.37 misses by $0.11, revenue of $5.59M misses by $8.72M (NASDAQ:OYST)
3 years ago - By: Oyster Point Pharma, Inc.
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
3 years ago - By: Kahn Swick & Foti, LLC
OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST
3 years ago - By: Weiss Law
- Mentions:
VTRS
SHAREHOLDER ALERT: Weiss Law Investigates Oyster Point Pharma, Inc.
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Oyster Point Pharma, Inc. has obtained a Fair Price in its transaction with Viatris
3 years ago - By: Halper Sadeh LLC
OYST Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Oyster Point Pharma, Inc. Is Fair to Shareholders
3 years ago - By: Oyster Point Pharma, Inc.
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
Please enable JavaScript to continue using this application.